Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD)

McMurray, JJ; Wheeler, DC; Stefansson, BV; Rotter, RC; Chertow, GM; Greene, T; Hou, FF; Lindberg, MB; Rossing, P; Sjostrom, D; Toto, RD; Langkilde, AM; Heerspink, HJL

CIRCULATION, 2020; 142 (24): E482